Allorion Therapeutics

Allorion Therapeutics

Verified
Next-generation precision medicine for oncology and autoimmune disease

Launch date
Employees
Ownership
Market cap
-
Net debt
-
Firm valuation
$160—240m (Dealroom.co estimates Nov 2021.)
Boston Massachusetts (HQ)
  • Edit

Recent News about Allorion Therapeutics

Edit